Echo45 Advisors’s Gilead Sciences GILD Stock Holding History

Echo45 Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$227K	Buy	+1,526	New	+$214K	0.1%	103

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Echo45 Advisors's GILD Position: Q3 2026 in Review

Echo45 Advisors opened a new position in Gilead Sciences (GILD) in Q3 2026: 1,526 shares worth $227K. The stake represents 0.1% of the portfolio and ranks #103 among its holdings.

501 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

Echo45 Advisors held 1,526 shares of Gilead Sciences worth $227K as of Q3 2026.
Gilead Sciences was a new Echo45 Advisors position in Q3 2026.
Gilead Sciences made up 0.1% of Echo45 Advisors's portfolio in Q3 2026, its #103 holding.
501 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Echo45 Advisors's 13F filing for Q3 2026, filed 7 Oct 2026.